Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers.
about
Possible existence of lysosome-like organella within mitochondria and its role in mitochondrial quality controlGenetic variants and risk of lung cancer in never smokers: a genome-wide association studyMethylation detection oligonucleotide microarray analysis: a high-resolution method for detection of CpG island methylation.PCDH18 is frequently inactivated by promoter methylation in colorectal cancer.Involvement of members of the cadherin superfamily in cancerA catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene.Whole-exome sequencing of primary plasma cell leukemia discloses heterogeneous mutational patterns.Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.Non-clustered protocadherinPCDH10 promoter hypermethylation is frequent in most histologic subtypes of mature lymphoid malignancies and occurs early in lymphomagenesis.Global methylation silencing of clustered proto-cadherin genes in cervical cancer: serving as diagnostic markers comparable to HPVDuodenal follicular lymphoma: comprehensive gene expression analysis with insights into pathogenesisPCDH20 functions as a tumour-suppressor gene through antagonizing the Wnt/β-catenin signalling pathway in hepatocellular carcinoma.Methylated Genes in Sputum Among Older Smokers With Asthma.Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancerPCDH8 is Frequently Inactivated by Promoter Hypermethylation in Liver Cancer: Diagnostic and Clinical Significance.Targeting PCDH20 gene by microRNA-122 confers 5-FU resistance in hepatic carcinomaTumor-specific hypermethylation of epigenetic biomarkers, including SFRP1, predicts for poorer survival in patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) project.Arginine methylation of USP9X promotes its interaction with TDRD3 and its anti-apoptotic activities in breast cancer cells.Protocadherin 17 functions as a tumor suppressor suppressing Wnt/β-catenin signaling and cell metastasis and is frequently methylated in breast cancer.Deletion of TOP3β, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders.Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.Decreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma.RNAi targeting GPR4 influences HMEC-1 gene expression by microarray analysis.Beyond E-cadherin: roles of other cadherin superfamily members in cancer.Arginine methylation facilitates the recruitment of TOP3B to chromatin to prevent R loop accumulation.Regulation of Wnt signaling by protocadherins.Protocadherin20 Acts as a Tumor Suppressor Gene: Epigenetic Inactivation in Nasopharyngeal Carcinoma.Aberrant expression and functions of protocadherins in human malignant tumors.Characterizing the role of PCDH9 in the regulation of glioma cell apoptosis and invasion.Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.Inhibition of collagen XVI expression reduces glioma cell invasiveness.Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma.PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer.PCDH9 acts as a tumor suppressor inducing tumor cell arrest at G0/G1 phase and is frequently methylated in hepatocellular carcinoma.PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation.BCL2L2 is a probable target for novel 14q11.2 amplification detected in a non-small cell lung cancer cell line.Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.
P2860
Q24338278-5EC8060A-E1E2-4440-89AF-1E095DCB1CEFQ28383607-ABBA68BE-230D-4BF6-8596-8C00776C8B3DQ30488766-8F20F604-5C9D-4181-BDCF-21EF8A0FE143Q33767601-1990E058-BA82-46D6-AB13-9D83ECA97DBAQ33899441-5C184493-7AC4-41D4-835B-DCA8673742B0Q34065944-E0F664B3-2456-46F7-9040-DE23E33C107FQ34479418-0443B55B-77F0-4BD1-8817-41A98CD2E7D2Q34544542-80ADB404-2888-479C-AADB-66675B65F175Q34787147-028A0829-BBF6-4C8F-8F85-C20114548539Q34891159-FFDFF000-1257-4EF4-8A06-C8E17C7468E3Q34912713-D16A3772-558B-41FC-8B8C-BE5256988D33Q35032304-20D878B9-55B4-4417-8D0E-8E5243881D3BQ35051585-B69FBF43-C954-4DCA-A8EF-4913CFBD371FQ35132214-2AD7E843-7BFC-48C6-9B04-F3F6FA3538FDQ36182205-E14F212F-93D9-4685-B148-1552D3DDDA7FQ36197642-CC3A6F86-DCCF-478F-B366-AEF106B2FE77Q36201483-43432BA8-FC6B-45AF-9A04-4A7F5EFA9061Q36567898-D71BDA4D-C430-4347-94BD-0FA3FD133E15Q37215530-F4F986B2-4C29-48EE-8E42-3163E2C05D35Q37484160-A1964FC1-6817-40BF-BAF4-4D649E1AF430Q37550449-4E909FEB-691B-4B16-A11F-C5BE9226D954Q37588356-1DE07CE8-B96A-4FAB-A94C-D66297DE8BBEQ37703015-45A221AB-4E05-4E7F-B3DA-0AA65A260EFCQ37709397-389272B8-8E01-4472-9222-D81F82B6C2D1Q37709418-B74190C0-DA3C-47DD-9B30-B2F8235E3200Q37711445-94340038-2A27-45A0-A58C-9500B5D7A5FFQ38179961-A1ACDC68-B0C3-4CEA-887D-BC3AC9179139Q38363569-29EE3C53-0276-4145-934E-07C873C05BC3Q38642725-0F86C37B-8690-4E6E-9739-5AD8A16F4950Q38903947-F718EB87-CA38-4FCC-BD80-5ADEAB0C3161Q38905879-6A16D02C-32F1-4E4E-A5B1-362E0FDAD61BQ39064803-10B254BA-FDEE-4DD5-8BC2-447393B9087CQ39465369-5EEF92D6-896A-4F81-90BB-6A6209D36910Q39562938-69FF5852-741F-4DDE-9F87-AF9FBDBB277BQ39732683-4B7DC64C-9071-4568-A94F-DFFDA4335C37Q39992398-664B8447-8E38-4BEA-A540-09F042D7D584Q40100942-C26EF130-0836-439C-A93F-D4B877651883Q40114074-64A1952F-DB1D-4968-9F94-45140DE9CF99Q40141213-E8A650CE-9FDA-4D3F-8EA9-DA81B59F5134Q40162770-91404FB1-F20C-4FD0-BB84-55E60B3B1136
P2860
Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Frequent silencing of the cand ...... n non-small-cell lung cancers.
@en
type
label
Frequent silencing of the cand ...... n non-small-cell lung cancers.
@en
prefLabel
Frequent silencing of the cand ...... n non-small-cell lung cancers.
@en
P2093
P1433
P1476
Frequent silencing of the cand ...... n non-small-cell lung cancers.
@en
P2093
Fumie Hosoda
Hiroshi Hosoda
Hiroyuki Izumi
Issei Imoto
Johji Inazawa
Misao Ohki
Sana Yokoi
Setsuo Hirohashi
Tatsuhiro Shibata
P304
P356
10.1158/0008-5472.CAN-05-4437
P407
P577
2006-05-01T00:00:00Z